Abstract: A medical composition for protuberance of epithelium, which comprises a solution comprising a polysaccharide or a medically acceptable salt thereof, wherein the solution has a viscosity of: (1) from 50 to 500 mPa·s at a shear rate of from 7.7 to 10.0 s?1; (2) from 45 to 300 mPa·s at a shear rate of from 19.2 to 20.0 s?1; and (3) from 40 to 200 mPa·s at a shear rate of from 38.3 to 40.0 s?1, when measured using a rotational viscometer at 25° C., and a syringe filled with the medical composition.

Abstract: An aminoalkoxystyrene represented by the formula (1) wherein R1 and R2 are C1-4 alkyl and n is 3-6. The aminoalkoxystyrene is prepared by reacting an aminoalkoxyphenylmagnesium halide with vinyl halide in the presence of a catalyst. A quaternized amino group-containing polymer made by quaternizing the amino groups of a polymer prepared from the aminoalkoxystyrene is useful as an anion exchanger.

Abstract: A medical composition for protuberance of epithelium, which comprises a solution comprising a polysaccharide or a medically acceptable salt thereof, wherein the solution has a viscosity of: (1) from 50 to 500 mPa·s at a shear rate of from 7.7 to 10.0 s?1; (2) from 45 to 300 mPa·s at a shear rate of from 19.2 to 20.0 s?1; and (3) from 40 to 200 mPa·s at a shear rate of from 38.3 to s?1, when measured using a rotational viscometer at 25° C., and a syringe filled with the medical composition.

Abstract: An aminoalkoxystyrene represented by the formula (1) wherein R1 and R2 are C1-4 alkyl and n is 3-6. The aminoalkoxystyrene is prepared by reacting an aminoalkoxyphenylmagnesium halide with vinyl halide in the presence of a catalyst. A quaternized amino group-containing polymer made by quaternizing the amino groups of a polymer prepared from the aminoalkoxystyrene is useful as an anion exchanger.

Abstract: A medical composition for protuberance of epithelium, which comprises a solution comprising a polysaccharide or a medically acceptable salt thereof, wherein the solution has a viscosity of: (1) from 50 to 500 mPa·s at a shear rate of from 7.7 to 10.0 s?1; (2) from 45 to 300 mPa·s at a shear rate of from 19.2 to 20.0 s?1; and (3) from 40 to 200 mPa·s at a shear rate of from 38.3 to 40.0 s?1, when measured using a rotational viscometer at 25° C., and a syringe filled with the medical composition.

Abstract: A medical composition for protuberance of epithelium, which comprises a solution comprising a polysaccharide or a medically acceptable salt thereof, wherein the solution has a viscosity of: (1) from 50 to 500 mPa·s at a shear rate of from 7.7 to 10.0 s?1; (2) from 45 to 300 mPa·s at a shear rate of from 19.2 to 20.0 s?1; and (3) from 40 to 200 mPa·s at a shear rate of from 38.3 to 40.0 s?1, when measured using a rotational viscometer at 25° C., and a syringe filled with the medical composition.

Abstract: A medical composition for protuberance of epithelium, which comprises a solution comprising a polysaccharide or a medically acceptable salt thereof, wherein the solution has a viscosity of: (1) from 50 to 500 mPa·s at a shear rate of from 7.7 to 10.0 s−1; (2) from 45 to 300 mPa·s at a shear rate of from 19.2 to 20.0 s−1; and (3) from 40 to 200 mPa·s at a shear rate of from 38.3 to 40.0 s−1, when measured using a rotational viscometer at 25° C., and a syringe filled with the medical composition.

Abstract: A process for the production of a styrene derivative is provided. The process comprises reacting a Grignard reagent prepared from an aromatic halogen compound with a vinyl halide in the presence of a catalyst, wherein the catalyst is at least one member selected from the group consisting of manganese catlyst, iron catalyst, cobalt catalyst and rhodium catalyst.

Abstract: A process for the production of a styrene compound is provided. The process comprises reacting a Grignard reagent prepared from a tertiary butoxyphenyl halide with a vinyl halide in the presence of a catalyst, wherein the catalyst is at least one member selected from the group consisting of manganese catalyst, iron catalyst, cobalt catalyst and rhodium catalyst. The process overcomes the problems involved in the prior art, and is economical and safe. The styrene compound by the process is free from biphenyl.

Abstract: A process for the production of a styrene compound is provided. The process comprises reacting a Grignard reagent prepared from a tertiary butoxyphenyl halide with a vinyl halide in the presence of a catalyst, wherein the catalyst is at least one member selected from the group consisting of manganese catalyst, iron catalyst, cobalt catalyst and rhodium catalyst. The process overcomes the problems involved in the prior art, and is economical and safe. The styrene compound by the process is free from biphenyl.

Abstract: A polyycarbonate resin coextruded article having a thermoplastic aromatic polycarbonate resin core layer and a thermoplastic aromatic polycarbonate resin cover layer which is provided on at least one side of the core layer, wherein the cover layer contains 0.1 to 25 parts by weight of a triazine light stabilizer represented by formula (I) per 100 parts by weight of the thermoplastic aromatic polycarbonate. wherein R1 represents an alkyl group having 1 to 17 carbon atoms; R2 represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms; and n represents an integer of 1 to 20.

Abstract: This invention provides pharmaceutical compositions containing chondroitinase wherein a decrease in enzyme activity is very little even after long-term storage, and the pharmaceutical compositions are characterized in that they contain chondroitinase and a pharmaceutical carrier, and that an amount of reducing impurities per 1 g of said pharmaceutical carrier is 0.4 mL or less as a titer by a titration method with 0.01 N of ammonium ceric nitrate.